Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceut...

FDA Recall #D-0306-2026 — Class III — January 21, 2026

Recall #D-0306-2026 Date: January 21, 2026 Classification: Class III Status: Ongoing

Product Description

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

Reason for Recall

Tablets/Capsules Imprinted with Wrong ID

Recalling Firm

Unichem Pharmaceuticals USA Inc. — East Brunswick, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

60,000 tablets

Distribution

Nationwide

Code Information

Lot # GDSH25006, Exp Date: 08/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated